IHS Chemical Week

World News and Views :: Top of the News

Lonza and Australian Firm Establish Manufacturing Alliance

12:32 AM MDT | September 27, 2011 | Deepti Ramesh

Lonza says it has entered into a strategic alliance with Mesoblast (Melbourne, Australia), a developer of innovative biological products for regenerative medicine, for clinical and long-term commercial production of Mesoblast’s off-the-shelf allogeneic adult stem cell products. The alliance will provide Mesoblast with certainty of capacity to meet long-term global supply of its proprietary mesenchymal precursor cell (MPC) products. “The cell therapy market is anticipated to become a major growth industry with the potential to mirror the growth we have...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa